Schedule 13G ownership disclosure
Keenova Therapeutics PLC
Security class unavailable · CUSIP: G5890A102
Event date: 2023-11-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-025399
- Form type
- SC 13G
- Filer
- MARATHON ASSET MANAGEMENT LP
- CIK
- CIK 1279913
- Filed
- Feb 06, 2024
- Reporting period
- Nov 14, 2023
- Description
- Schedule 13G beneficial ownership